A patient manifesting symptoms of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome was found to carry a mutation in MRM2 (Garone et al., 2017). Here, MRM2 is linked to MELAS syndrome.